
About Polydex
Polydex is a publicly listed company based in Toronto (Canada) founded in 1969. It operates as a bulk dextran and derivatives are manufactured for pharmaceutical companies. Polydex offers products and services including Dextran Powder, Dextran Sulfate Sodium Salt, Dextran Solution with Preservative, Arginine Hydrochloride, and Bis-Tris. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and API Production. Similar companies include Laurus Labs, Sterling Pharma Solutions, Provepharm Life Solutions, Symbiotec and Jubilant Pharma and 3 more; 5 of its 8 listed similar companies have raised funding.
Company details
Polydex was founded in 1969 in Toronto, Canada. Bulk quantities of dextran and derivative products are produced and distributed to major pharmaceutical firms globally. Ferric hydroxide and hydrogenated dextran are provided through its subsidiary, Chemdex. The company operates within the pharmaceutical manufacturing sector, supporting drug development with specialized chemical supplies.
- Headquarters Toronto, Canada
- Stage Public
- SectorsHealthcare
- Website polydex.com
- Social LinkedIn
Products & Services of Polydex
Polydex offers a comprehensive portfolio of products and services, including Dextran Powder, Dextran Sulfate Sodium Salt, Dextran Solution with Preservative, Arginine Hydrochloride, and Bis-Tris.
Powder in various molecular weights for industrial applications
Sulfate derivative for life science uses
Liquid form for biotech applications
Synthetic chemical for GMP processes
Chemical for laboratory and pharm uses
Synthetic compound for biotech applications
Plant-derived for EP and NF standards
Synthetic for USP-compliant uses
For NF and GMP applications
Free acid for laboratory processes
Similar companies to Polydex
Polydex has 8 listed similar companies in our database, 5 of them funded. They include Laurus Labs, Sterling Pharma Solutions, Provepharm Life Solutions, Symbiotec and Jubilant Pharma, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lauruslabs.com | 2005 | Hyderabad, India | $229.73M | 6,035 | Pharmaceutical and biotechnology company | |
| sterlingpharmasolutions.com | 2016 | Dudley, United Kingdom | – | 560 | Contract development, manufacturing, and analytical services for APIs are offered. | |
| provepharm.com | 1998 | Marseille, France | $145.93M | – | APIs and drug products are developed and valorized in pharmaceuticals. | |
| symbiotec.in | 2002 | Indore, India | $61.01M | 1,822 | Non-sterile steroid hormone-based APIs and intermediates are manufactured. | |
| jubilantpharma.com | 1978 | Noida, India | – | – | Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company. | |
| apicore.com | 2004 | Somerset, United States | $720,118 | 518 | APIs are manufactured and custom synthesis services are provided. | |
| sequent.in | 2002 | Bengaluru, India | – | – | APIs are developed and manufactured for therapeutic areas. | |
| bellenchem.com | 2007 | Beijing, China | $52.56M | – | APIs and intermediates are researched and manufactured, specializing in heterocycles. |
Detailed similar companies of Polydex
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Polydex
Websites that share an audience with Polydex (polydex.com).
Websites whose visitors overlap most with Polydex. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
aitanchem.com | aitanchem.com | 100% | – | – | β |
argosi.com.cn | argosi.com.cn | 100% | – | – | β |
gayatrionline.com | gayatrionline.com | 100% | – | – | β |
| amidrugs.com | 100% | – | – | View details | |
pantoproducts.com | pantoproducts.com | 100% | – | – | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 20 similar websites and full traffic analytics for Polydex
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 20 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
10 companies that operate in the same segment as Polydex (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 255.15 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Polydex
Complete news archive for Polydex
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Polydex
Polydex was founded in 1969.
Polydex is headquartered in Toronto, Canada. It is registered at Toronto, Ontario, Canada.
Polydex was founded in 1969 in Toronto, Canada. Bulk quantities of dextran and derivative products are produced and distributed to major pharmaceutical firms globally. Ferric hydroxide and hydrogenated dextran are provided through its subsidiary, Chemdex. The company operates within the pharmaceutical manufacturing sector, supporting drug development with specialized chemical supplies.
Polydex's top competitors include Laurus Labs, Symbiotec and Sterling Pharma Solutions.
Polydex offers Dextran Powder, Dextran Sulfate Sodium Salt, Dextran Solution with Preservative, Arginine Hydrochloride, and 6 more products and services.
